Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Bespak – 21.05.2025
Stoelzle – 15th May 2025

Time to Put the Spotlight on the Substance of your Drugs through Solid-form Development

The global pharmaceutical industry generated more than $1.25tr in revenue in 2019, up from $1.2tr in 2018, and the final figures for 2020 are expected to be even more impressive. In such a fast-paced environment, pharmaceutical companies need to do all they can to ensure their products, no matter whether they are new innovations or improvements to existing active pharmaceutical ingredient (API) solids, stand out in the market. The question facing pharmaceutical companies is: how to? John Mykytiuk at Sterling Pharma Solutions explains that the answer to achieving these all-important enhancements lies in perfecting the physical characteristics of the API solid itself through solid-form development.

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025